-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UGq64FLL42jjITANaePaEqcnZBIKAUTTjW/Yv3uJhrC287UhGSoWNpdlpA72yrXt vsyLOO53BR+9RgjbOOX28g== 0000903423-09-000886.txt : 20091104 0000903423-09-000886.hdr.sgml : 20091104 20091104104831 ACCESSION NUMBER: 0000903423-09-000886 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091104 DATE AS OF CHANGE: 20091104 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CURAGEN CORP CENTRAL INDEX KEY: 0001030653 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061331400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-53811 FILM NUMBER: 091156619 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVENUE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 781 433 0771 MAIL ADDRESS: STREET 1: 119 FOURTH AVENUE CITY: NEEDHAM STATE: MA ZIP: 02494 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAYER AKTIENGESELLSCHAFT CENTRAL INDEX KEY: 0001144145 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: BAYERWERK, GEBAEUDE W11 STREET 2: KAISER-WILHELM-ALLEE CITY: LEVERKUSEN STATE: 2M ZIP: D-51368 BUSINESS PHONE: 492143081933 MAIL ADDRESS: STREET 1: BAYERWERK, GEBAEUDE W11 STREET 2: KAISER-WILHELM-ALLEE CITY: LEVERKUSEN STATE: 2M ZIP: D-51368 SC 13G/A 1 bayersc13g_1104.htm

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

CuraGen Corporation

(Name of Issuer)

Common Shares, par value $0.01 per share

(Title of Class of Securities)

23126R101

(CUSIP Number)

October 5, 2009

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

		o	Rule 13d-1(b)
		x	Rule 13d-1(c)
		o	Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 23126R101
1.	Name of Reporting Person Bayer AG
2.	Check the Appropriate Box if a Member of a Group (a) o (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization Germany
Number of shares beneficially owned by each reporting person with		5.	Sole Voting Power 0
		6.	Sole Voting Power 0
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 0
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 0%
12.	Type of Reporting Person (See Instructions) CO

STATEMENT ON SCHEDULE 13G

Item 1.

(a)	Name of Issuer:
	CuraGen Corporation
(b)	Address of Issuer’s Principal Executive Offices:
	322 East Main Street, Branford, Connecticut 06405
Item 2.
(a)	Name of Person Filing:
	Bayer AG
(b)	Address of Principal Business Office or, if none, Residence:
	D-52368 Leverkusen, Germany
(c)	Citizenship:
	Germany
(d)	Title of Class of Securities:
	Common Shares, par value $0.01 per share
(e)	CUSIP Number:
	23126R101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	Not applicable

Item 4.	Ownership

(a) Amount Beneficially Owned: 0

(b) Percent of Class: 0%

(i) Sole power to vote or to direct the vote: 0

(ii) Shared power to vote or to direct the vote: 0

(iii) Sole power to dispose or to direct the disposition of: 0

(iv) Shared power to dispose or to direct the disposition of: 0

Item 5.	Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x
Item 6.	Ownership of More than Five Percent on Behalf of Another Person
	Not applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
	Not applicable
Item 8.	Identification and Classification of Members of the Group
	Not applicable
Item 9.	Notice of Dissolution of Group
	Not applicable.
Item 10.	Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: November 4, 2009

	Bayer AG
By:	/s/ ppa. Dr. Armin Buchmeier Name: Dr. Armin Buchmeier Title: Individual authorized signatory with full power of representation

By:	/s/ ppa. Dr. Michael Hermann Name: Dr. Michael Hermann Title: Individual authorized signatory with full power of representation

-----END PRIVACY-ENHANCED MESSAGE-----